SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-030137
Filing Date
2024-06-26
Accepted
2024-06-26 16:04:19
Documents
13
Period of Report
2024-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fhtx-20240626.htm   iXBRL 8-K 38907
  Complete submission text file 0001628280-24-030137.txt   166665

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20240626.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20240626_lab.xml EX-101.LAB 22543
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20240626_pre.xml EX-101.PRE 13047
16 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20240626_htm.xml XML 2829
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 241073414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)